Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 128002281 | 12800228 | 1 | I | 20160923 | 20160930 | 20160930 | EXP | GR-AMGEN-GRCSP2016131737 | AMGEN | 75.00 | YR | E | F | Y | 0.00000 | 20160930 | MD | GR | GR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 128002281 | 12800228 | 1 | PS | XGEVA | DENOSUMAB | 1 | Unknown | UNK | 125320 | UNKNOWN FORMULATION | |||||||||
| 128002281 | 12800228 | 2 | SS | EXEMESTANE. | EXEMESTANE | 1 | Unknown | UNK | 0 | ||||||||||
| 128002281 | 12800228 | 3 | SS | TAMOXIFEN CITRATE. | TAMOXIFEN CITRATE | 1 | Unknown | UNK | 0 | ||||||||||
| 128002281 | 12800228 | 4 | SS | LETROZOLE. | LETROZOLE | 1 | Unknown | UNK | 0 | ||||||||||
| 128002281 | 12800228 | 5 | SS | FULVESTRANT | FULVESTRANT | 1 | Unknown | UNK | 0 | ||||||||||
| 128002281 | 12800228 | 6 | SS | EVEROLIMUS | EVEROLIMUS | 1 | Unknown | UNK | 0 | ||||||||||
| 128002281 | 12800228 | 7 | SS | CAPECITABINE. | CAPECITABINE | 1 | Unknown | UNK | 0 | ||||||||||
| 128002281 | 12800228 | 8 | SS | ZOLEDRONIC | ZOLEDRONIC ACID | 1 | Unknown | UNK | 0 | ||||||||||
| 128002281 | 12800228 | 9 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | UNK | 0 | ||||||||||
| 128002281 | 12800228 | 10 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 128002281 | 12800228 | 11 | C | CALCIUM | CALCIUM | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 128002281 | 12800228 | 1 | Breast cancer metastatic |
| 128002281 | 12800228 | 2 | Breast cancer metastatic |
| 128002281 | 12800228 | 3 | Breast cancer metastatic |
| 128002281 | 12800228 | 4 | Breast cancer metastatic |
| 128002281 | 12800228 | 5 | Breast cancer metastatic |
| 128002281 | 12800228 | 6 | Breast cancer metastatic |
| 128002281 | 12800228 | 7 | Breast cancer metastatic |
| 128002281 | 12800228 | 8 | Breast cancer metastatic |
| 128002281 | 12800228 | 9 | Breast cancer metastatic |
| 128002281 | 12800228 | 10 | Breast cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 128002281 | 12800228 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 128002281 | 12800228 | Disease progression | |
| 128002281 | 12800228 | Osteonecrosis of jaw |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 128002281 | 12800228 | 1 | 2014 | 0 | ||
| 128002281 | 12800228 | 2 | 201211 | 0 | ||
| 128002281 | 12800228 | 5 | 2012 | 0 | ||
| 128002281 | 12800228 | 6 | 201211 | 0 | ||
| 128002281 | 12800228 | 7 | 201601 | 0 | ||
| 128002281 | 12800228 | 8 | 201211 | 2014 | 0 |